MedTrace Logo

JASP-1 for Children Recently Diagnosed and Their Parents

NCT06284616 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2024-03-06

No results posted yet for this study

Summary

To implement and evaluate a patient-and family-centered Juvenile Arthritis Support Program during one year (JASP-1) for children recently diagnosed with JIA and their parents and after 12 months compare satistaction with care and health outcomes with a control group receiving standard care.

Conditions

  • JIA
  • Support Program
  • Patient Satisfaction
  • Patient Outcome Assessment

Interventions

BEHAVIORAL

JASP-1

patients following the Juvenile Arthritis Support Program at the Pediatric Rheumatology Clinic

Sponsors & Collaborators

  • Region Stockholm

    lead OTHER_GOV

Principal Investigators

  • Eva Broström, Professor · Supervisor

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-15
Primary Completion
2023-04-15
Completion
2023-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06284616 on ClinicalTrials.gov